Document is current
Any future updates will be listed below
-
Authors
DiPalma, Devon T https://orcid.org/0000-0003-0603-3084
Lumbreras, Miranda K https://orcid.org/0000-0002-7200-5826
Shinohara, Mari L https://orcid.org/0000-0002-6808-9844
-
Funding
Funding for this research was provided by:
HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI088100)
HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI160737)
HHS | NIH | National Institute of Neurological Disorders and Stroke (R01-NS120417)
NSF | National Science Foundation Graduate Research Fellowship Program (DGE-2139754)
- License Information
-
More Information
Article History
Received: 20 March 2025
Revised: 28 May 2025
Accepted: 2 June 2025
First Online: 17 June 2025
Disclosure and competing interests statement
: MLS currently receives funds from Ono Pharmaceuticals, Co. Ltd. to unrelated topics covered in this review.
